Join to View Full Profile
505 Parnassus Ave# M1087San Francisco, CA 94143
Fax+1 415-476-5712
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christopher Ryerson, MD is a pulmonologist in San Francisco, California.
Certifications & Licensure
American Board of Anesthesiology Anesthesiology
Clinical Trials
- The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease Start of enrollment: 2010 Feb 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Publications & Presentations
PubMed
- Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography.Christopher J Ryerson, Daniel-Costin Marinescu, Nestor L Muller, Cameron J Hague, Darra Murphy
American Journal of Respiratory and Critical Care Medicine. 2025-06-12 - 2 citationsTranscriptomics of interstitial lung disease: a systematic review and meta-analysis.Daniel He, Sabina A Guler, Casey P Shannon, Christopher J Ryerson, Scott J Tebbutt
The European Respiratory Journal. 2025-06-01 - 3 citationsAccelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung disease.Gillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, Jean Bourbeau, Christopher Carlsten
The European Respiratory Journal. 2025-06-01
Press Mentions
Low BMI, Weight Loss Predict Mortality Risk in ILDJanuary 4th, 2022
What the Health?! Can Feather Duvets Really Cause Lung Disease?November 29th, 2019
Transbronchial Lung Cryobiopsy a Valid Diagnostic Option in Interstitial Lung DiseaseOctober 7th, 2019- Join now to see all
